Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...
Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...
In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid ...
Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its new drug application for zongertinib (BI 1810631) for the treatment of adult ...
Thad McLaurin was diagnosed with Stage 4 lung cancer in 2023. After the diagnosis, he was recommended different treatment ...
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...
Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...
During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...
can help detect lung cancer. To confirm the diagnosis, one may need a biopsy too, which involves taking a tissue sample from the lungs. Lung metastasis treatment often involves a combination of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback